Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GAP Trial: Abraxane and Gemcitabine in Locally Advanced Pancreatic Cancer
NCT02043730Phase 2Completed
- Sponsor
- Fondazione Giscad per la Ricerca sui Tumori
- Start
- Jan 2014
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of paclitaxel in pancreatic cancer (PC) (2 arms), sponsored by Fondazione Giscad per la Ricerca sui Tumori. Primary endpoint: Progression Rate. Started Jan 2014; status: completed.
02
Drugs
paclitaxel
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT02043730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02043730.